An influenza pandemic is a large scale epidemic of the influenza virus, such as the 1918 Spanish flu. The World Health Organization (WHO) warns that there is a substantial risk of an influenza pandemic within the next few years. One of the strongest candidates is a highly pathogenic variation of the H5N1 subtype of avian influenza which is rapidly mutating and could mutate into a variation that transmits easily human to human causing a pandemic. If such a mutation occurs, it might remain an H5N1 subtype or could shift subtypes as did H2N2 when it evolved into the Hong Kong Flu strain of H3N2.
In a bad pandemic, some communities cut themselves off totally while others have half their population die. People try every remedy they can think of. [1] There are not enough doctors, hospital rooms, or medical supplies for the living and dead bodies pile up faster than they can be dealt with. There is great social disruption and efforts to deal with the pandemic always leave a great deal to be desired due to selfishness, lack of trust, illegal behavior, and ignorance. For example in the 1918 pandemic "This horrific disconnect between reassurances and reality destroyed the credibility of those in authority. People felt they had no one to turn to, no one to rely on, no one to trust." [2]
A letter from a physician at one U.S. Army camp in the 1918 pandemic said:
Flu pandemics typically come in waves. The 1889–1890 and the 1918-1919 flu pandemics each came in three or four waves of increasing lethality. [4] But within a wave, mortality was greater at the beginning of the wave. [5]
Mortality varies widely in a pandemic. In the 1918 pandemic:
If avian influenza remains an animal problem with limited human-to-human transmission it is not a pandemic, though it continues to pose a risk.
To prevent the situation from progressing to a pandemic, the following short-term strategies have been put forward:
The rationale for vaccinating poultry workers against common flu is that it reduces the probability of common influenza virus recombining with Avian H5N1 virus in the bloodstream of poultry workers to form a pandemic strain.
Longer term strategies proposed for regions where highly pathogenic H5N1 is endemic in wild birds have included:
A vaccine probably would not be available in the initial stages of population infection [8]. Once a potential virus is identified, it normally takes at least several months before a vaccine becomes widely available, as it must be developed, tested and authorized. The capability to produce vaccines varies widely from country to country; in fact, only 15 countries are listed as "Influenza vaccine manufacturers" according to the World Health Organization [9]. It is estimated that, in a best scenario situation, 750 million doses could be produced each year, whereas it is likely that each individual would need two doses of the vaccine in order to become inmuno-competent. Distribution to and inside countries would probably be problematic [10]. Several countries, however, have well-developed plans for producing large quantities of vaccine. For example, Canadian health authorities say that they are developing the capacity to produce 32 million doses within four months, enough vaccine to inoculate every person in the country. [11]
According to the US HHS (United States Department of Health & Human Services) Pandemic Influenza Plan Appendix F: Current HHS Activities last revised on November 8, 2005 and located here:
Many nations, as well as the World Health Organization, are working to stockpile anti-viral drugs in preparation for a possible pandemic. Oseltamivir (trade name Tamiflu) is the most commonly sought drug, since it is available in pill form. Zanamivir (trade name Relenza) is also considered for use, but it must be inhaled. Other anti-viral drugs are less likely to be effective against pandemic influenza.
Both Tamiflu and Relenza are in short supply, and production capabilities are limited in the medium term. Some doctors say that co-administration of Tamiflu with probenecid could double supplies[12].
There also is the potential of viruses to evolve drug resistance. Some H5N1-infected persons treated with oseltamivir have developed resistant strains of that virus.
Tamiflu was originally discovered by Gilead Sciences and licensed to Roche for late-phase development and marketing.
Donald Rumsfeld, the major shareholder in Gilead Sciences, has profited from the US government stockpiling of oseltamivir in case of an influenza pandemic. [13] Critics have used this fact to question both government stockpiling policies and the H5N1 potential pandemic itself.
(The World Health Organization published a compendium of non-pharmaceutical interventions in November 2005. The following list is not identical to the WHO recommendations.)
In the case of a flu pandemic, to avoid the risk of contracting H5N1 (or indeed, any other strain of the flu virus) people may have to take certain precautions, and make changes to their routine, to minimise the risk of infection. They may also have to prepare for the possibility of their lives being disrupted in a significant way, even if they do not actually become ill.
A flu pandemic could cause major disruption to everyday life, with footpaths and the countryside being partially or even totally off-limits, and even restrictions on public gatherings (such as public meetings, parties, services at places of worship), quarantine, and bans on individuals travelling to certain locations. However, there are a number of things people could do to prepare themselves:
Keep a supply of water and food. During a pandemic you may not be able to get to a store. Even if you can get to a store, it may be out of supplies or it may not be safe to enter it. Public waterworks services may also be interrupted. Stocking supplies can be useful in other types of emergencies. Store foods that:
Will the seasonal flu shot protect me against pandemic influenza?
Take common-sense steps to limit the spread of germs. Make good hygiene a habit.
It is always a good idea to practice good health habits.
Knowing the facts is the best preparation. Identify sources you can count on for reliable information. If a pandemic occurs, having accurate and reliable information will be critical. Listen to local and national radio, watch news reports on television, and read your newspaper and other sources of printed and Web-based information. Talk to your local health care providers and public health officials. Read your government Web sites. As you begin your individual or family planning, you may want to review your state's planning efforts and those of your local public health and emergency preparedness officials.
Experts agree that a lethal pandemic will have a negative effect on the world and local economies.
The World Health Organization announces the current phase of the pandemic alert here.
See "Assessing the pandemic threat" at [17]. WHO published a first edition of the Global Influenza Preparedness Plan in 1999, and updated it in April 2005. See [18] and [19] which define the responsibilities of WHO and national authorities in case of an influenza pandemic. This is the first time a pandemic has been anticipated and is being prepared for.
The aims of such plans are, broadly speaking, the following:
The World Health Organization (WHO) has developed a global influenza preparedness plan, which defines the stages of a pandemic, outlines WHO's role and makes recommendations for national measures before and during a pandemic.
Investigations of small clusters of cases are currently ongoing in southeast Asia, particularly Vietnam, to rule out limited human-to-human spread (which would signify Phase 4). The phases are defined as:
Phase 1: Low risk No new influenza virus subtypes dangerous to humans detected in humans or animals.
Phase 2: New virus A new circulating animal influenza virus subtype poses a substantial risk of human disease but no new influenza virus subtypes have been detected in humans.
Phase 3: Self limiting Human infection(s) with a new subtype, but no human-to-human spread, or at most rare instances of spread to a close contact. Even without human intervention it would be self limiting among humans.
Phase 4: Person to person: Small cluster(s) with limited human-to-human transmission but spread is highly localized, suggesting that the virus is not well adapted to humans. An epidemic is possible but has not yet happened.
Phase 5: Epidemic: Larger cluster(s) but human-to-human spread still localized, suggesting that the virus is becoming increasingly well adapted to humans, but may not yet be fully transmissible (substantial pandemic risk).
Phase 6: Pandemic: increased and sustained transmission in general population.
The distinction between phase 1 and phase 2 is based on the risk of human infection or disease resulting from circulating strains in animals. The distinction is based on various factors and their relative importance according to current scientific knowledge. Factors may include pathogenicity in animals and humans, occurrence in domesticated animals and livestock or only in wildlife, whether the virus is enzootic or epizootic, geographically localized or widespread, and/or other scientific parameters.
The distinction between phase 3, phase 4 and phase 5 is based on an assessment of the risk of a pandemic. Various factors and their relative importance according to current scientific knowledge may be considered. Factors may include rate of transmission, geographical location and spread, severity of illness, presence of genes from human strains (if derived from an animal strain), and/or other scientific parameters.
The pandemic stage 6 may be marked by two or more waves. For example, the initial wave of the Spanish Influenza pandemic in the spring of 1918 was so mild in its effects that it received the dismissive nickname of the "three day flu." But when the second wave hit North America a few months later in the summer of 1918, it was lethal. Apparently in the interim the novel H1N1 pandemic strain had added the gene or genes that made the final wave a killer. Perhaps the effects of the lethal second wave would have been even more devastating if the innocuous first wave had not already passed through the population, leaving in its wake at least some immune response to the surface antigens presented by the H1N1 in both waves.
CIDRAP provides a thoroughgoing overview, Pandemic Influenza, which has its roots in materials from the U.S. HHS National Vaccine Program Office. CIDRAP's overview originally set forth a model listing five numbered stages for the pandemic itself, preceded by four additional pre-pandemic stages, each numbered as zero, that overlapped the WHO's first five stages of a pandemic. CIDRAP's overview has since adopted the WHO's 6-stage model.
"[T]he United States is collaborating closely with eight international organizations, including the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), the World Organization for Animal Health (OIE), and 88 foreign governments to address the situation through planning, greater monitoring, and full transparency in reporting and investigating avian influenza occurrences. The United States and these international partners have led global efforts to encourage countries to heighten surveillance for outbreaks in poultry and significant numbers of deaths in migratory birds and to rapidly introduce containment measures. The U.S. Agency for International Development (USAID) and the U.S. Department of State, the U.S. Department of Health and Human Services (HHS), and Agriculture (USDA) are coordinating future international response measures on behalf of the White House with departments and agencies across the federal government." [20]
Together steps are being taken to "minimize the risk of further spread in animal populations", "reduce the risk of human infections", and "further support pandemic planning and preparedness". [21]
Ongoing detailed mutually coordinated onsite surveillance and analysis of human and animal H5N1 avian flu outbreaks are being conducted and reported by the USGS National Wildlife Health Center, the Centers for Disease Control and Prevention, the World Health Organization, the European Commission, the National Influenza Centers, and others. [22]
In September 2005, David Nabarro, a lead UN health official warned that a bird flu outbreak could happen anytime and had the potential to kill 5-150 million people. [23]
"[E]fforts by the federal government to prepare for pandemic influenza at the national level include a $100 million DHHS initiative in 2003 to build U.S. vaccine production. Several agencies within Department of Health and Human Services (DHHS) — including the Office of the Secretary, the Food and Drug Administration (FDA), CDC, and the National Institute of Allergy and Infectious Diseases (NIAID) — are in the process of working with vaccine manufacturers to facilitate production of pilot vaccine lots for both H5N1 and H9N2 strains as well as contracting for the manufacturing of 2 million doses of an H5N1 vaccine. This H5N1 vaccine production will provide a critical pilot test of the pandemic vaccine system; it will also be used for clinical trials to evaluate dose and immunogenicity and can provide initial vaccine for early use in the event of an emerging pandemic." [24]
On August 26, 2004, Secretary of Health and Human Services, Tommy Thompson released a draft Pandemic Influenza Response and Preparedness Plan [25], which outlined a coordinated national strategy to prepare for and respond to an influenza pandemic. Public comments were accepted for 60 days.
In a speech before the United Nations General Assembly on September 14, 2005, President George W. Bush announced the creation of the International Partnership on Avian and Pandemic Influenza. The Partnership brings together nations and international organizations to improve global readiness by:
On October 5, 2005, Democratic Senators Harry Reid, Evan Bayh, Dick Durbin, Ted Kennedy, Barack Obama, and Tom Harkin introduced the Pandemic Preparedness and Response Act as a proposal to deal with a possible outbreak. ([26])
On October 27, 2005, the Department of Health and Human Serviced awarded a $62.5 million contract to Chiron Corporation to manufacture an avian influenza vaccine designed to protect against the H5N1 influenza virus strain. This followed a previous awarded $100 million contract to sanofi pasteur, the vaccines business of the sanofi-aventis Group, for avian flu vaccine.
In October 2005, President Bush urged bird flu vaccine manufacturers to increase their production. [27] .
On November 1, 2005 President Bush unveiled the National Strategy To Safeguard Against The Danger of Pandemic Influenza [28]. He also submited a request to Congress for $7.1 billion to begin implementing the plan. The request includes $251 million to detect and contain outbreaks before they spread around the world; $2.8 billion to accelerate development of cell-culture technology; $800 million for development of new treatments and vaccines; $1.519 billion for the Departments of Health and Human Services (HHS) and Defense to purchase influenza vaccines; $1.029 billion to stockpile antiviral medications; and $644 million to ensure that all levels of government are prepared to respond to a pandemic outbreak.
On 06 March 2006, Mike Leavitt, Secretary of Health and Human Services, said U.S. health agencies are continuing to develop vaccine alternatives that will protect against the evolving avian influenza virus. [29] .
The U.S. government, bracing for the possibility that migrating birds could carry a deadly strain of bird flu to North America, plans to test nearly eight times as many wild birds starting in April 2006 as have been tested in the past decade. [30] .
On 08 March 2006, Dr. David Nabarro, senior U.N. coordinator for avian and human influenza, said that given the flight patterns of wild birds that have been spreading avian influenza (bird flu) from Asia to Europe and Africa, birds infected with the H5N1 virus could reach the Americas within the next six to 12 months. [31]